Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Ireland

Ireland

The Diagnostic Imaging Devices market market in Ireland is anticipated to achieve a revenue of US$134.30m by the year 2024.
It is expected to display a compound annual growth rate (CAGR 2024-2029) of 3.72%, leading to a market volume of US$161.20m by 2029.
When compared globally, the United States is projected to generate the highest revenue, amounting to US$11,930.00m in 2024.
Ireland's Diagnostic Imaging Devices market is experiencing a surge in demand, driven by advancements in medical technology and increasing healthcare investments.

Key regions: Netherlands, China, Italy, Spain, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in Ireland has been experiencing steady growth in recent years.

Customer preferences: Customers in Ireland have shown a strong preference for advanced diagnostic imaging devices that offer high-quality imaging capabilities and improved patient comfort. They are also increasingly seeking devices that are portable and easy to use, allowing for greater flexibility in healthcare settings. Additionally, there is a growing demand for imaging devices that offer advanced features such as 3D imaging and artificial intelligence (AI) algorithms for more accurate and efficient diagnosis.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Ireland is the increasing adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, easier storage and retrieval of images, and the ability to enhance and manipulate images for better diagnosis. As a result, healthcare facilities in Ireland are investing in digital imaging devices such as digital X-ray systems and digital mammography systems. Another trend in the market is the rising demand for ultrasound devices. Ultrasound technology is non-invasive and does not involve the use of ionizing radiation, making it a safer option for both patients and healthcare professionals. Ultrasound devices are widely used for various diagnostic purposes, including obstetrics, cardiology, and musculoskeletal imaging. The increasing prevalence of chronic diseases and the growing aging population in Ireland are driving the demand for ultrasound devices.

Local special circumstances: Ireland has a well-developed healthcare system with a strong emphasis on providing high-quality healthcare services to its population. The government has been investing in the healthcare infrastructure, including the procurement of advanced diagnostic imaging devices, to ensure timely and accurate diagnosis for patients. Additionally, Ireland is home to several leading medical device manufacturers, which contributes to the availability of a wide range of diagnostic imaging devices in the market.

Underlying macroeconomic factors: The growth of the Diagnostic Imaging Devices market in Ireland is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to increased healthcare spending. The government has allocated a significant portion of its healthcare budget to the procurement of medical devices, including diagnostic imaging devices. Furthermore, the favorable reimbursement policies and the presence of private health insurance coverage in Ireland have also contributed to the growth of the market. In conclusion, the Diagnostic Imaging Devices market in Ireland is witnessing steady growth due to customer preferences for advanced imaging capabilities, the adoption of digital imaging technologies, and the increasing demand for ultrasound devices. The local special circumstances, such as the well-developed healthcare system and the presence of leading medical device manufacturers, further contribute to the growth of the market. The underlying macroeconomic factors, including economic growth and favorable reimbursement policies, also play a significant role in driving the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.